Prosecution Insights
Last updated: August 18, 2026
Application No. 17/594,905

SILICONE-BASED ADHESIVE PROTECTION FILM AND OPTICAL MEMBER COMPRISING SAME

Final Rejection §112
Filed
Nov 02, 2021
Priority
May 09, 2019 — RE 10-2019-0054556 +1 more
Examiner
DUCHENEAUX, FRANK D
Art Unit
1788
Tech Center
1700 — Chemical & Materials Engineering
Assignee
Samsung SDI Co., Ltd.
OA Round
5 (Final)
44%
Grant Probability
Moderate
6-7
OA Rounds
0m
Est. Remaining
30%
With Interview

Examiner Intelligence

Grants 44% of resolved cases
44%
Career Allowance Rate
320 granted / 719 resolved
-20.5% vs TC avg
Minimal -14% lift
Without
With
+-14.4%
Interview Lift
resolved cases with interview
Typical timeline
3y 7m
Avg Prosecution
46 currently pending
Career history
776
Total Applications
across all art units

Statute-Specific Performance

§101
0.4%
-39.6% vs TC avg
§103
48.2%
+8.2% vs TC avg
§102
12.9%
-27.1% vs TC avg
§112
32.2%
-7.8% vs TC avg
Black line = Tech Center average estimate • Based on career data from 719 resolved cases

Office Action

§112
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Response to Amendment Applicant’s arguments, see the claim amendments and the remarks filed 5/27/2026, with respect to the rejection of claim 9 under 35 U.S.C. 112(d) as set forth in paragraph 6 of the action mailed 3/2/2026, have been fully considered and are persuasive. The rejection of claim 9 has been withdrawn. Rejections The text of those sections of Title 35, U.S. Code not included in this action can be found in a prior Office action. Claim Rejections - 35 USC § 112 Claim 16 is rejected under 35 U.S.C. 112(d) or pre-AIA 35 U.S.C. 112, 4th paragraph, as being of improper dependent form for failing to further limit the subject matter of the claim upon which it depends, or for failing to include all the limitations of the claim upon which it depends. Applicant may cancel the claim(s), amend the claim(s) to place the claim(s) in proper dependent form, rewrite the claim(s) in independent form, or present a sufficient showing that the dependent claim(s) complies with the statutory requirements. Regarding claim 16, the current claim recites that component (ii) is a straight organic polysiloxane, which does not further limit the linear organic polysiloxane of current claim 1. Allowable Subject Matter Claims 1-6, 9-12 and 14 and claims 7-8 and claim 13 are allowed. The following is a statement of reasons for the indication of allowable subject matter: The closest prior art reference is: The Examiner notes that a reasonable interpretation of presently recited Formula 2 of component (ii) demonstrates the following requirements: only the (R1R2SiO2/2)x moiety is required of the claimed invention give that x = 1, y = 0, z = 0, and thus x + 0 + 0 = 1; R3, R4, R5, and R6 are not required; only one of R1 and R2 needs to be a vinyl group; SiO4/2 moieties are excluded from Formula 2. US 2017/0029571 A1 to Kusunoki et al. teaches an addition curable silicone composition (organic polysiloxane composition) to form a film (para 0132) comprising an adhesive aid (silicone-based adhesive protective film) (para 0134), and comprising: (A) a linear organopolysiloxane having at least two alkenyl groups per molecule; (B) an organopolysiloxane having at least 4 terminal hydrosilyl groups per molecule (crosslinking agent); and (C) a hydrosilylation catalyst (abstract). General formula (1) (para 0046) teaches the structure of component (B), with an exemplary structure given in paragraph 0054 of the reference, wherein it is noted that the -SiH structure is provided at various pendant placements, including at two of the ends (i.e., at Si-H group at both ends). Kusunoki also teaches that component (A) has the structure given by formula (11) with at least two of R11 being an hexenyl group (component (i), organic polysiloxane having at least one silicon-bonded C3 to C10 alkenyl group per molecule) (para 0088-0089). Kusunoki further teaches that silicone composition comprises (D) an organopolysiloxane having at least two alkenyl groups per molecule, such as two vinyl groups, and given by formula (12) (para 0102-0104). The Examiner notes that formula (12) is given by (R113SiO1/2)o (R112SiO2/2)p (R11SiO3/2)q (SiO4/2)r with r = 0 (free from SiO4/2 unit), and, for example, o = 1, p = 1 and q = 1, and thus formula (12) is given by, (R113SiO1/2)o (R112SiO2/2)p (R11SiO3/2)q Moreover, the inventive examples of Kusunoki demonstrate that the disclosed invention was intended to demonstrate an elongation of 80 to 180% and a tensile strength of less than 5 MPa (Table 2, para 0208). While Formula (12) teaches the structure given by, (R113SiO1/2)o (R112SiO2/2)p (R11SiO3/2)q, and while Formula 2 presently claimed does not specifically include the (R113SiO1/2)o and (R11SiO3/2)q units of Kusunoki, it does not specifically exclude them; and wherein the (R112SiO2/2)p moiety of said formula (12) teaching the presently claimed, (R1R2SiO2/2)x, x + y + z = 1, y and z = 0, R1 and/or R2 a vinyl group However, Formula (12) of the cited prior art does require the (R11SiO3/2)q unit (i.e., q = 1), and thus Formula (12) cannot have a linear structure as required by at least current claim 1 and current claim 7. Current claim 13 does not require that component (ii) comprises a linear organic polysiloxane as in current claim 1, but Kusunoki is silent to the curable silicone composition further comprising at least one of components (iii) and/or (iv) Claim 16 would be allowable if rewritten to overcome the rejection(s) under 35 U.S.C. 112(d) or 35 U.S.C. 112 (pre-AIA ), 4th paragraph, set forth in this Office action and to include all of the limitations of the base claim and any intervening claims. Conclusion Applicant's amendment necessitated the new ground(s) of rejection presented in this Office action. Accordingly, THIS ACTION IS MADE FINAL. See MPEP § 706.07(a). Applicant is reminded of the extension of time policy as set forth in 37 CFR 1.136(a). A shortened statutory period for reply to this final action is set to expire THREE MONTHS from the mailing date of this action. In the event a first reply is filed within TWO MONTHS of the mailing date of this final action and the advisory action is not mailed until after the end of the THREE-MONTH shortened statutory period, then the shortened statutory period will expire on the date the advisory action is mailed, and any nonprovisional extension fee (37 CFR 1.17(a)) pursuant to 37 CFR 1.136(a) will be calculated from the mailing date of the advisory action. In no event, however, will the statutory period for reply expire later than SIX MONTHS from the mailing date of this final action. Any inquiry concerning this communication or earlier communications from the examiner should be directed to FRANK D DUCHENEAUX whose telephone number is (571)270-7053. The examiner can normally be reached 8:30 PM - 5:00 PM. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Alicia A Chevalier can be reached at 571-272-1490. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /FRANK D DUCHENEAUX/Primary Examiner, Art Unit 1788 7/14/2026
Read full office action

Prosecution Timeline

Show 4 earlier events
Jun 26, 2025
Response after Non-Final Action
Jul 30, 2025
Request for Continued Examination
Aug 03, 2025
Response after Non-Final Action
Oct 16, 2025
Non-Final Rejection mailed — §112
Dec 30, 2025
Response Filed
Mar 02, 2026
Non-Final Rejection mailed — §112
May 27, 2026
Response Filed
Jul 16, 2026
Final Rejection mailed — §112 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12698419
Temperature-Changeable Adhesive Sheet and Temperature-Changeable Adhesive Sheet Manufacturing Method Using Same
6y 4m to grant Granted Aug 04, 2026
Patent 12686800
ADHESIVE AGENT COMPOSITION, SURFACE PROTECTION FILM, AND METHOD OF MANUFACTURING ORGANIC LIGHT-EMITTING ELECTRONIC DEVICE
5y 2m to grant Granted Jul 21, 2026
Patent 12686797
Acrylic-Based Adhesive Composition with Ethylene-Based Polymer
3y 4m to grant Granted Jul 21, 2026
Patent 12674046
ADHESIVE FORMULATIONS BASED ON ETHYLENE MULTI-BLOCK INTERPOLYMERS AND FUNCTIONALIZED PROPYLENE-BASED POLYMERS
3y 5m to grant Granted Jul 07, 2026
Patent 12655335
SEALANT SHEET
5y 5m to grant Granted Jun 16, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

6-7
Expected OA Rounds
44%
Grant Probability
30%
With Interview (-14.4%)
3y 7m (~0m remaining)
Median Time to Grant
High
PTA Risk
Based on 719 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month